Regeneron Pharmaceuticals Dives On $1.1 Billion Deal To Rival Merck In Cancer

Published on 2 Jun 2022 on Investor's Business Daily

On today's stock market, however, Regeneron stock toppled 4.3% to 630.70. Shares of Sanofi stock...

Read the rest of the article

Start tracking your investments with Statfolio

Verona Pharma stock jumped 10.6% that day. During an investor breakfast, company executives were...

Investor's Business Daily 16 Jan 2025

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a cor...

Motley Fool · via Yahoo Finance 16 Jan 2025

Merck is developing tulisokibart, a novel TL1A inhibitor, for the treatment of UC, CD and other...

Zacks · via Yahoo Finance 16 Jan 2025

KYMR outlines plans to advance its immunology candidates. As of Dec. 31, 2024, KYMR had $850 mill...

Zacks · via Yahoo Finance 15 Jan 2025

France stocks higher at close of trade; CAC 40 up 0.20%

Investing.com 14 Jan 2025

Sanofi's Sarclisa SC formulation shows non-inferiority versus Sarclisa IV infusion in a late-stag...

Zacks · via Yahoo Finance 14 Jan 2025

Moderna Inc. ended last year with the dubious distinction of having seen the biggest drop in valu...

The Business Journals 14 Jan 2025

Jefferies downgraded IGM Biosciences (IGMS) to Hold from Buy with a price target of $2, down from...

TipRanks · via Yahoo Finance 11 Jan 2025

IGMS stock fell 68% during Friday's trading session on the news. The business is stopping further...

GuruFocus.com · via Yahoo Finance 10 Jan 2025

Sanofi's Sarclisa SC formulation shows non-inferiority versus Sarclisa IV infusion in a late-stag...

Zacks · via Yahoo Finance 10 Jan 2025